Page 34 - Exact Sciences News Today

COVID-19 created unprecedented demand for in vitro diagnostic expertise and products, and Kalorama Informations latest market research report pro...

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will...

First Lady Jill Biden visited Madison on Thursday — as the national political parties have turned their focus to Wisconsin in preparation for the 2024 elections — to highlight the

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.

A consortium of 15 Wisconsin organizations has submitted an application to the federal government to pursue the designation of a regional tech hub.

/PRNewswire/ -- In vitro diagnostics (IVDs) remain dynamic. The IVD market is a high R&D spend industry with constant innovations and routine interest from...

Between universities, biotech firms and manufacturers state group says Wisconsin in position to be national leader in personalized medicine

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.

Colorectal cancer is the third most common cancer worldwide, and although the majority of colorectal cancer cases have historically occurred in individuals aged 45 and older, it is increasingly affecting younger people.

Major players in the whole exome sequencing market are Thermo Fisher Scientific Inc., Illumina Inc., Eurofins Genomics, Azenta US Inc., CD Genomics,...